As Connecticut’s medical cannabis program begins to treat individuals suffering from chronic pain, the state says it’s expecting the number of registered patients to nearly double in the coming years.
That will significantly increase demand for medical cannabis products; Connecticut currently has more than 41,500 registered adult and pediatric medical cannabis patients.
Connecticut Pharmaceutical Solutions Inc. (CTPharma), one of the state’s four licensed medical cannabis growers, says it’s planning to meet that need by dramatically increasing its footprint in a 216,500-square-foot warehouse/distribution center in Rocky Hill recently vacated by pharmaceutical giant McKesson Corp. CTPharma currently occupies just 15,000 square feet in Portland.
On a recent tour of the new site, at 280 Dividend Road, CTPharma Chief Operations Officer Rino Ferrarese estimated the pharmaceutical company will invest roughly $30 million to renovate the space it acquired for $7.5 million in February. The project’s first phase will be completed in early July, he said, making room for the immediate arrival of hundreds of cannabis plants.
Read more at hartfordbusiness.com
